Health Care Technology
Acuitive Technologies Introduces Citregraft, A Unique Bone Graft Substitute Designed To Bind Proteins And Enhance Regeneration
Share
ALLENDALE, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Acuitive Technologies® commercializes Citregraft™, with its first use in a surgical case, performed on November 4th, 2025.
Bone graft substitutes are used to repair defects from trauma, infection, tumor removal, and reconstructive surgery. However, poor handling, low biological activity, variable resorption rate, and inadequate integration limit their effectiveness.
Leveraging the benefits of citrate in bone anatomy and physiology, Acuitive Technologies developed Citregen®, a citrate-based polymer technology that mimics natural bone chemistry and supplies the energy needed for regeneration. Exclusively made with Citregen and bioactive glass, Citregraft is a highly porous and bioactive synthetic bone graft substitute designed to interact with proteins to regenerate bony voids within the skeletal system.
Citregraft benefits include:
- Bioactive formulation to improve graft integration
- Easily morselized to fill and hold its position within irregular defects
- Absorbs 5 times its weight in fluids
- Synergizes with bone marrow aspirate (BMA) to bind proteins
- Citrate increases cell energy for tissue regeneration
“Citregraft was easily morselized to fill my tibial harvest site during BPTB ACL reconstruction. After soaking it in saline, it readily absorbed blood and growth factors from the harvest site and conformed perfectly to the defect,” said Robin Gehrmann, MD.
Citregraft overcomes the limitations of conventional bone graft substitutes by improving handling, liquid uptake, and protein binding. Its demonstrated bioactivity and ability to bind proteins establish Citregraft as a viable option for surgeons seeking innovative solutions for bone repair and regeneration.
Media Contact
Thomas McCarthy
Acuitive Technologies, Inc.
tmccarthy@acuitivetech.com
https://www.acuitivetech.com/
Data on file, TM251008, at Acuitive Technologies Inc., Allendale, NJ, USA
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/233ecf43-c685-4d77-ba95-b1a49b14eecb
Frequently Asked Questions
What is Citregraft?
Citregraft is a highly porous and bioactive synthetic bone graft substitute designed to interact with proteins to regenerate bony voids within the skeletal system. It's made with Citregen and bioactive glass.
What are the benefits of Citregraft?
Benefits include improved graft integration, easy morselization to fill irregular defects, high fluid absorption, and synergy with bone marrow aspirate.
How does Citregraft improve bone regeneration?
Citregraft utilizes Citregen, a citrate-based polymer technology that mimics natural bone chemistry and supplies the energy needed for regeneration. It overcomes limitations of conventional bone graft substitutes by improving handling, liquid uptake, and protein binding.
First published on Thu, Nov 20, 2025
Liked what you read? That’s only the tip of the tech iceberg!
Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!
Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.
Dive into TechDogs' treasure trove today and Know Your World of technology like never before!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
The Apache Software Foundation Announces New Top-Level Projects
Thrive Honors 2026 Outstanding Partner Award Winners
Wolters Kluwer Appoints Maria Montenegro As CEO Of Corporate Performance & ESG Division
Predis.Ai Announces Launch Of New State-Of-The-Art (SOTA) AI Models For Ad Videos
SEO As Easy As Using A Toaster: Tech Startup Replaces Complex Analytics With Simplicity And A Ranking Guarantee
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion